| DESCRIPTION OF ENHANCEMENTS |
Defect Tracking System Ticket(s) & Overview:
eRx queue. This is preventing us from processing these orders if the
community prescriber does not submit their DEA number. The problem is
that the inbound eRX contains a digital signature and the provider does
not have a DEA# sent in the eRX message and the drug is not a controlled
drug. This causes an error to be encountered when processing it in PSO
ERX FINISH. The error is 'eRx Provider does not have a valid DEA#.'
Resolution:
-----------
Routine PSOERXUT is modified to not return an error when the eRX drug is
not a controlled drug and the provider doesn't have a DEA# and the eRX is
digitally signed.
Technical Resolution:
---------------------
PSOERXUT is modified at line PRDRVAL+58^PSOERXUT to add the condition
ACTION=-"AC"
Line PRDRVAL+58^PSOERXUT after the code change:
. I ACTION="EP"!(ACTION="VP")!(ACTION="AC"),'VACSDRUG D Q ;p718 add
1. INC25956349 - INBOUND ERX FOR NON-CONTROLLED SUBSTANCES COMING
accept action
THROUGH AS CONTROLLED
Problem:
--------
Site is receiving several inbound eRx for non-controlled substance
medications that are designated as controlled substances in the inbound
|
